Oncodiagnosis panel: 1999: Cancer of the lung: Oncodiagnosis

Radiographics

Volumn 21, Issue 6, 2001, Pages 1573-1596

  Komaki, Ritsuko ^a   Chasen, Marvin H ^a   Travis, William D ^b   Putnam, Joe B ^a   Fossella, Frank V ^a   Byhardt, Roger W ^c   Ro, Jae Y ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Lung neoplasms, diagnosis, 60.32; Lung neoplasms, metastases, **.33 2; Lung neoplasms, staging, 60.32; Lung neoplasms, surgery, 60.32; Lung neoplasms, therapeutic radiology, 60.32; Lung neoplasms, therapy, 60.32

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; HUMAN; LUNG TUMOR; MALE; PATHOLOGY; RADIOGRAPHY;

ADULT; AGED; HUMANS; LUNG NEOPLASMS; MALE;

EID: 0035512236     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.21.6.g01nv311573     Document Type: Article

References (102)

1. American Cancer Society. Cancer statistics. CA Cancer J Clin 2000; 50:12-32.
2. Meyers CA, Byrne KS, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 1995; 12:231-236.
3. Quoix E, Fraser R, Wolkove N, Finkelstein H, Kreisman H. Small cell lung cancer presenting as a solitary pulmonary nodule. Cancer 1990; 66: 577-582.
4. Kreisman H, Wolkove N, Quoix E. Small cell lung cancer presenting as a solitary pulmonary nodule. Chest 1992; 101:225-231.
5. Patz EF, Lowe VJ, Goodman PC, Herndon J. Thoracic nodal staging with PET imaging with 18-FDG in patients with bronchogenic carcinoma. Chest 1995; 108:1617-1621.
6. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996; 111:642-648.
7. Gupta NC, Graeber GM, Rogers JS 2nd, Bishop HA. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Ann Surg 1999; 229:286-291.
8. Coleman RE. Clinical PET in oncology. Clin Positron Imaging 1998; 1:15-30.
9. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36:788-793.
10. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37:943-948.
11. Coleman RE. PET in lung cancer. J Nucl Med 1999; 40:814-820.
12. Erasmus J, Patz EF, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxy-glucose positron emission tomography. AJR Am J Roentgenol 1997; 168:1357-1360.
13. Erasmus JJ, McAdams HP, Patz EF, et al. Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18F-fluorodeoxyglucose. AJR Am J Roentgenol 1998; 170:1369-1373.
14. Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998; 39: 1016-1020.
15. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small cell lung cancer. J Nucl Med 1996; 37:1428-1436.
16. Travis WD, Colby TV, Corrin B, et al. Histological typing of lung and pleural tumours. World Health Organization International Histological Classification of Tumours. Berlin, Germany: Springer-Verlag, 1999.
17. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22:934-944.
18. Osterlind K, Hansen HH, Hansen M, et al. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol 1986; 4:1307-1313.
19. Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993; 329:1848-1852.
20. Elias AD, Ayash L, Frei E, et al. Intensive combined modality therapy for limited stage small cell lung cancer. J Natl Cancer Inst 1993; 85: 559-566.
21. McCracken JD, Janaki LM, Crowley JJ, et al. Concurrent chemotherapy/radiotherapy for limited small cell lung carcinoma: a Southwest Oncology Group study. J Clin Oncol 1992; 8:892-898.
22. Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340:265-271.
23. Aisner J. Extensive disease small cell lung cancer: the thrill of victory, the agony of defeat. J Clin Oncol 1996; 14:658-665.
24. Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited stage small cell lung cancer. J Clin Oncol 1996; 14:821-828.
25. Carney DN. Lung cancer biology. Semin Radiat Oncol 1995; 5:4-10.
26. Stahel RA, Weber E. Small cell lung cancer: the new biology. Semin Radiat Oncol 1995; 5:11-18.
27. Paesmans M, Sculler JP, Lecomte J, et al. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 2000; 89:523-533.
28. Bunn PA, Ihde DC. Small-cell bronchogenic carcinoma: a review of therapeutic results. In: Livingston RB, ed. Lung cancer. Vol 1. The Hague, The Netherlands: Martinus Nijhoff, 1981; 169-208.
29. Lassen U, Hansen HH. Surgery in limited stage small cell lung cancer. Cancer Treat Rev 1999; 25:67-72.
30. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-1717.
31. Namikawa S, Den T, Kimura M, Kusagawa M. The role of surgical resection and the effects of neo-adjuvant therapy in the management of small cell lung cancer. Surg Today 1994; 24:342-346.
32. Kohman LJ. Is there a place for surgery in central small cell lung cancer? Chest Surg Clin N Am 1997; 7:105-112.
33. Lucchi M, Mussi A, Chella A, et al. Surgery in the management of small cell lung cancer. Eur J Cardiothorac Surg 1997; 12:689-693.
34. Urschel JD. Surgical treatment of peripheral small cell lung cancer. Chest Surg Clin N Am 1997; 7:95-103.
35. Kobayashi S, Okada S, Hasumi T, Sato N, Fujimura S. Combined modality therapy including surgery for stage III small-cell lung cancer on the basis of the sensitivity assay in vitro. Surg Today 2000; 30:127-133.
36. Bonomi P. Review of selected randomized trials in small cell lung cancer. Semin Oncol 1998; 25(4suppl9):70-78.
37. Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus: ten-year follow-up. Lancet 1973; 2:63-65.
38. DeVore RF, Johnson DH. Chemotherapy of small cell lung cancer. Lung Cancer 1996; 56: 825-898.
39. Pignon JP, Arriagada R, Ihde DC, et al. A metaanalysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327:1618-1624.
40. Komaki R. Management of limited small cell lung cancer. Int J Clin Oncol 2000; 5:205-216.
41. Choi NC, Herndon JE, Rosenman J, et al. Phase I study to determine the maximum tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited small-cell lung cancer. J Clin Oncol 1998; 16:3528-3536.
42. Turrisi AT, Glover DJ, Mason BA. A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 1988; 15:184-187.
43. Kummermehr J, Dorr W, Trott KR. Kinetics of accelerated repopulation in normal and malignant squamous epithelium during fractionated therapy. BJR Suppl 1992; 24:193-199.
44. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989; 16:83-101.
45. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-146.
46. Goldie JH, Goldman AJ, Gudauskas GA. Rationale for the use of alternating non-cross resistant chemotherapy. Cancer Treat Rep 1982; 66:439-449.
47. Murray N, Coy P, Pater J, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 1993; 11:336-344.
48. Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987; 316:912-918.
49. Turrisi A. Limited small cell lung cancer (LSCLC): concurrent BID thoracic radiotherapy (TRT) with platinum-etoposide (PE) - an ECOG study (abstr). In: Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology, 1990; 230.
50. Johnson BE, Bridges JD, Sobczeck M, et al. Patients with limited-stage small cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol 1996; 14:806-813.
51. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission: a meta-analysis of individual data from 987 patients. N Engl J Med 1999; 341:476-484.
52. Gregor A. Cranial irradiation in small cell lung cancer. Br J Cancer 1991; 63:13-14.
53. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995; 33:179-182.
54. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. Eur J Cancer 1997; 33:1752-1758.
55. Woodring JH. Determining the cause of pulmonary atelectasis: a comparison of plain radiography and CT. AJR Am J Roentgenol 1988; 150: 757-763.
56. Naidich DP, Webb WR, Muller NL, et al. Lobar atelectasis. In: Naidich DP, Webb WR, Muller NL, Krinsky GA, Zerhouni EA, Siegelman SS, eds. Computed tomography and magnetic resonance imaging of the thorax. 3rd ed. Philadelphia, Pa: Lippincott, 1999; 228-241.
57. Libshitz HI. Radiation changes in the lung. Semin Roentgenol 1993; 28:303-320.
58. Libshitz HI, Shuman LS. Radiation-induced pulmonary change: CT findings. J Comput Assist Tomogr 1984;8:15-19.
59. Miller JD, Gorenstein LA, Patterson GA. Staging: the key to rational management of lung cancer. Ann Thorac Surg 1992; 53:170-178.
60. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723.
61. Patterson GA, Piazza D, Pearson FG, et al. Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg 1987; 43:155-159.
62. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323.
63. American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia, Pa: Lippincott-Raven, 1997; 127-137.
64. Fowler WC, Langer CL, Curran WC, Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993; 55:986-989.
65. Rusch VW, Albain KS, Crowley JJ, et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. J Thorac Cardiovasc Surg 1993; 105:97-106.
66. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastasis to the brain: a randomized trial. JAMA 1998; 280:1485-1489.
67. Pisters KW, Ginsberg RJ, Bunn PA. Induction chemotherapy prior to surgery for early stage lung cancer: a novel approach (abstr). In: Proceedings of the 79th Annual Meeting of the American Association for Thoracic Surgery. Manchester, Mass: American Association for Thoracic Surgery, 1999; 140.
68. Resell R, Gomez-Condina J, Camps C, et al. A randomized trial of preoperative chemotherapy plus surgery versus surgery in non small cell lung cancer. N Engl J Med 1993; 330:153-158.
69. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994; 86:673-680.
70. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung Cancer 1994; 10:S239-S244.
71. Dillman R, Seagren S, Propert K, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 323:940-945.
72. Sause W, Kolesar P, Taylor S IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000; 117:358-364.
73. Schaake-Koning C, Van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326:524-530.
74. Byhardt R, Scott C, Ettinger D, et al. Concurrent hyperfractionation irradiation and chemotherapy for unresectable non-small cell lung cancer: results of Radiation Therapy Oncology Group 90-15. Cancer 1995; 75:2337-2344.
75. Lee J, Scott C, Komaki R, et al. Concurrent chemoradiation therapy with oral etoposide and cis-platin for locally advanced inoperable non-small cell lung cancer: RTOG protocol 91-06. J Clin Oncol 1996; 14:1055-1064.
76. Jeremic B, Jevremovic S, Mijatovic L, Milisavljevic S. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer. Cancer 1993; 71:3732-3736.
77. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999; 17:2692-2699.
78. Curran WJ Jr, Scott C, Langer R, et al. Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): initial report of Radiation Therapy Oncology Group (RTOG) 9410 (abstr). In: Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology, 2000; 484.
79. Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology 1989; 170:637-641.
80. Naidich DP, Webb WR, Muller NL, et al. Role of MR in staging lung cancer. In: Naidich DP, Webb WR, Muller NL, Krinsky GA, Zerhouni EA, Siegelman SS, eds. Computed tomography and magnetic resonance imaging of the thorax. 3rd ed. Philadelphia, Pa: Lippincott, 1999; 364-368.
81. Attar S, Krasna MJ, Sonett JR, et al. Superior sulcus (Pancoast) tumor: experience with 105 patients. Ann Thorac Surg 1998; 66:193-198.
82. Strojan P, Debevec M, Kovac V. Superior sulcus tumor: management at the Institute of Oncology in Ljubljana, Slovenia 1981-1994. Lung Cancer 1997; 17:249-259.
83. Shaw RR, Paulson DL, Kee JL Jr. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961; 154:29-40.
84. Paulson DL. Technical considerations in stage III disease: the "superior sulcus" lesion. In: Delarue NC, Eschapasse H, eds. Lung cancer. Philadelphia, Pa: Saunders, 1985; 121-131.
85. Miller JI, Mansour KA, Hatcher CRJr. Carcinoma of the superior pulmonary sulcus. Ann Thorac Surg 1979; 28:44-47.
86. Komaki R, Putnam JB Jr, Walsh G, et al. The management of superior sulcus tumors. Semin Surg Oncol 2000; 18:152-164.
87. Herbert SH, Curran WJ Jr, Stafford PM, et al. Comparison of outcome between clinically staged, unresected superior sulcus tumors and other stage III non-small cell lung carcinomas treated with radiation therapy alone. Cancer 1992; 69:363-369.
88. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer: Lung Cancer Study Group. Ann Thorac Surg 1995; 60:615-623.
89. Ginsberg RJ. Resection of a superior sulcus tumor. Chest Surg Clin N Am 1995; 5:315-331.
90. York JE, Walsh GL, Lang FF, et al. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 1999; 91(1 suppl):74-80.
91. Gokaslan ZL, York JE, Walsh GL, et al. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 1998; 89:599-609.
92. Dartevelle PG, Chapelier AR, Macchiarini P. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105:1025-1034.
93. Dartevelle P, Macchiarini P. Surgical management of superior sulcus tumors. Oncologist 1999; 4:398-407.
94. Kraut MJ, Rusch VW, Crowley JJ, Gandara DR. Induction chemoradiation plus surgical resection is a feasible and highly effective treatment for Pancoast tumors: initial results of SWOG 9416 (Intergroup 00160) trial (abstr). In: Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology, 2000; 487.
95. Paulson DL. Superior sulcus carcinomas. In: Sabiston DC, Sponsor FC, eds. Gibbon's surgery of the chest. 4th ed. Philadelphia, Pa: Saunders, 1976; 506-515.
96. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89(4 suppl): 225S-233S.
97. Komaki R. Preoperative radiation therapy for superior sulcus lesions. Chest Surg Clin N Am 1991; 1:13-35.
98. Komaki R, Derus S, Perez-Tamayo C, Byhardt R, Hartz A, Cox J. Brain metastasis in patients with superior sulcus tumors. Cancer 1987; 59: 1649-1653.
99. Komaki R, Mountain CF, Holbert JM, et al. Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (MO) at presentation. Int J Radiat Oncol Biol Phys 1990; 19:31-36.
100. Sause W, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:198-205.
101. Stoll B A, Andrews JT. Radiation-induced peripheral neuropathy. Br Med J 1966; 1:834-836.
102. Thomas JE, Colby MY. Radiation-induced or metastatic brachial plexopathy? A diagnostic dilemma. JAMA 1972; 222:1392-1395.